 |
Kekst & Co is handling Avista Capital Markets private equity firm's merger of a "blank check company" with Organogenesis Inc. advanced wound care and sports medicine operation.
ACM has agreed to invest $92M in Canton, MA-based Organogenesis, which is expected to trade on the NASDAQ with an enterprise value in the $675M range when the deal closes by the end of the year.
Organogenesis has more than 600 employees involved in the development, manufacture and commercialization of products in the regenerative medicine sector.
Tom Dean, CEO of Avista Healthcare Public Acquisition Corp., said Organogenesis is "well-positioned to benefit from secular tailwinds driving the advance would care, surgical and sports medicine sectors."
Kekst's Daniel Yunger reps Avista and AHPAC.
Caterpillar’s Rob Rengel will join ATI Inc. on June 22 as VP-investor relations, succeeding the retiring David Weston.
Hut 8, energy infrastructure platform, has named NextEra Energy's Mark Eidelman head of IR and SVP of strategic finance.
Teneo handles easyJet as Minneapolis investment firm Castlelake mulls a possible takeover of the British budget airline.
Brunswick Group represents Universal Music Group as it rejects the unsolicited $65B takeover offer by billionaire Ed Ackman's Pershing Square Capital Management because it “fundamentally and materially undervalues” the world’s largest music company.
Prosek Partners brings on Danielle O’Brien as a managing director in its investor relations practice, based in the firm’s New York office.
